Jul 16, 2026 04:10PM
Jul 13, 2026 07:01AM
Jul 10, 2026 07:00AM
Jun 26, 2026 08:25AM
Jun 24, 2026 08:41AM
May 6, 2026 07:07AM
Feb 23, 2026 07:02AM InMode ends review process, rejects all transaction proposals
Feb 10, 2026 07:03AM
Feb 2, 2026 07:02AM
Jan 28, 2026 05:13PM
Jan 28, 2026 05:06PM
Jan 26, 2026 09:05AM
Jan 8, 2026 07:03AM
Nov 5, 2025 07:07AM InMode Ltd. (INMD) Tops Q4 EPS by 2c ; Offers Guidance
Oct 10, 2025 06:34AM
Oct 10, 2025 04:51AM
Oct 9, 2025 09:56AM
Sep 9, 2025 08:15AM
Jul 30, 2025 07:04AM
Jul 10, 2025 08:27AM
May 28, 2025 08:33AM InMode Ltd. (INMD) Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
May 9, 2025 08:23AM
May 6, 2025 08:03AM
Apr 29, 2025 07:23AM
Apr 29, 2025 05:35AM
Apr 28, 2025 07:04AM
Apr 15, 2025 06:37AM
Apr 14, 2025 01:12PM Jefferies Maintains InMode Ltd. (INMD) at Hold, Lowers PT, '1Q Prelims Below Cons; FY25 Guide Reiterated But Requires Step-Up; Hold'
Mar 6, 2025 07:31AM
Feb 4, 2025 07:03AM
Feb 4, 2025 07:03AM
Jan 15, 2025 08:05AM
Jan 8, 2025 02:30PM
Jan 8, 2025 09:26AM
Oct 30, 2024 07:06AM InMode Ltd. (INMD) Tops Q4 EPS by 9c ; Offers Guidance
Oct 24, 2024 07:04AM
Oct 16, 2024 04:07PM
Oct 11, 2024 06:28AM
Oct 10, 2024 12:37PM
Oct 10, 2024 08:58AM
Oct 1, 2024 02:59PM
Oct 1, 2024 02:30PM Canaccord Genuity Reiterates Hold Rating on InMode Ltd. (INMD)
Oct 1, 2024 07:01AM
Sep 10, 2024 02:29PM
Sep 10, 2024 07:00AM
Aug 1, 2024 07:23AM
Jul 25, 2024 08:16AM
Jul 23, 2024 01:40AM
Jul 17, 2024 08:04AM InMode Ltd. (INMD): Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
Jul 12, 2024 07:49AM

419,348 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All